We sought to determine the outcome of suicidal hanging and the impact of targeted temperature management (TTM) on hanginginduced cardiac arrest (CA) through an Eastern Association for the Surgery of Trauma (EAST) multicenter retrospective study.
H
anging is the second most common cause of suicide in the United States after firearms, claiming more than 10,000 lives each year. The percentage of hanging among suicidal attempts increased from 19% in 2000 to 26% in 2010, while suicides caused by firearm decreased from 56% to 50% during the same time. 1 Furthermore, the increases in suicidal hanging were greatest in females 10 to 24 years of age 2 and in the middle-aged population. 3 Given the significant mortality of suicidal hanging, 4, 5 these staggering statistics highlight a significant public health problem. To date, no treatment has been shown to improve the outcome of hanging patients. Targeted temperature management (TTM) has been shown to improve the survival and neurologic outcome of shockable 6, 7 and nonshockable 8 cardiac arrest (CA) survivors. Previous animal 9 and neonatal studies 10 demonstrated that TTM is beneficial after hypoxic encephalopathy caused by asphyxia. Case reports 11, 12 and small retrospective studies [13] [14] [15] [16] [17] have also shown the potential benefits of TTM after asphyxial CA. However, the randomized TTM trials to date have mainly focused on shockable rhythms and excluded asphyxial arrest. 6, 7, 18, 19 Therefore, the role of TTM in hanging-induced CA management remains unknown.
We previously showed in a single-center retrospective study that hanging patients who had CA had significantly higher severity of illness and worse outcome than those who did not have CA. 20 We demonstrated that post-CA TTM was feasible for hanging patients, but our study did not have enough power to detect outcome differences between the TTM and non-TTM hanging patients. As such, we sought to further investigate the outcome of suicidal hanging and the impact of TTM on hanginginduced CA through an Eastern Association for the Surgery of Trauma multicenter retrospective study. We hypothesized that a larger cohort size would allow us to identify outcome predictors and detect TTM-associated outcome differences in hanging patients.
METHODS
Seventeen centers participated in this multicenter retrospective study (Supplemental Table 1 , Supplemental Digital Content, http://links.lww.com/TA/B161). Data from 692 patients with hanging as injury type were deidentified and entered into a secured American Association for the Surgery of Trauma online data portal (https://secure.myispartner.com/Trauma/login.aspx). We collected patients' demographics, prehospital and admission data, Utstein variables, 21 laboratory and diagnostics studies, TTM variables and complications, and discharge outcome from January 1992 to December 2015. The first hanging patient was identified in 1992, while the first TTM patient was from 2005. All 692 patients were analyzed for overall patient demographic and outcome (Table 1) . We then excluded 24 patients who were dead on arrival from subsequent analyses. Dead on arrival was defined as those who were pulseless on arrival and never achieved return of spontaneous circulation (ROSC) despite resuscitative efforts. Cerebral anoxia was defined as radiologic evidence of anoxia on brain computed tomography (CT) scans. A cerebral performance category (CPC) score of 1 or 2 was considered good neurologic outcome, while a CPC score of 3 or 4 was considered poor outcome. 22 This study was approved by the institutional review boards at the participating centers.
We used χ 2 tests to compare categorical variables, and their effect sizes were expressed as frequencies (n) and percentages (%). We used Mann-Whitney U-tests to compare continuous variables, and their effect sizes were expressed as medians and interquartile ranges (IQRs). A two-sided p < 0.05 indicated statistical significance. These statistical analyses were performed using SAS 9.4 (SAS Institute Inc., Cary, NC) and SPSS 25 (IBM Corp., Armonk, NY).
We used Classification and Regression Trees (CART) recursive partitioning to develop multivariate predictive models for survival and good neurologic outcome. All available prehospital and admission data were included in the CART model development. We used the Gini coefficient to determine the best split. To build the most optimal trees, we cross-validated each tree 10 times using a boot-strapping technique, in which the model was developed using 90% of the patients and then tested using patients not included in the tree development. The most stable trees were selected. [23] [24] [25] [26] [27] Areas under the receiver operating characteristics (AUROCC) with 95% confidence interval (CI) were determined to evaluate model accuracy. Because the application of TTM was not randomly assigned to our study population, and patients who received TTM might have differed inherently from those who did not, we developed separate CART models by forcing the first split to be on TTM. As prior studies have defined medical futility as likelihood for success of less than 3%, 28 we predefined 3% or less as very low, greater than 3% to 25% or less as low, greater than 25% to 75% or less as average, greater than 75% to less than 97% as high, and 97% or greater as very high probability for survival or good neurologic outcome. The CART analyses were performed with SPM Salford Predictive Modeler (Salford Systems, San Diego, CA).
RESULTS
Total of 692 hanging patients from 17 centers were analyzed for this study. Their mean age was 32 years (IQR, 24-43 years); 80.5% were male, and 68.4% were white. Their overall survival rate was 77%, and the survival rate for CA patients was 28.6%. A significant portion of hanging patients had psychiatric disorders (58.2%), prior suicide attempt (23.1%), alcohol abuse (22.7%), tobacco use (22.3%), and drug abuse (14.5%). The most frequent injury locations were private residence (61%) and prison (24%; Table 1 ). Of the 692 hanging patients, 199 (28.8%, including 24 dead on arrival) had CA. Of the 175 CA patients who survived to hospital admission, 81 patients (46.3%) received post-CA TTM, while 16 of 493 non-CA patients (3.2%) received TTM (Fig. 1) .
The CA patients had significantly higher severity of illness and worse outcome than non-CA patients. The CA patients had higher Injury Severity Score (ISS), higher Abbreviated Injury Scale Head score, lower systolic blood pressure (SBP) and heart rate, lower admission temperature, and higher lactate and base excess. The CA patients also had higher incidences of cervical spine bony and spinal cord injuries, blunt cerebrovascular injuries, and upper airway injuries. Finally, they had worse prehospital and admission Glasgow Coma Scale (GCS) scores, higher incidence of cerebral anoxia on CT scans (54.3% vs 11.4%, p < 0.001), worse survival (28.6% vs 96.6%, p < 0.001), and fewer good neurologic outcome (25.6% vs 94.3%, p < 0.001) at hospital discharge compared to the non-CA patients. The length of survival after hospital discharge was largely unknown (70.7% unknown; Table 1 ). The CA patients who received TTM had higher severity of illness than the non-TTM CA patients. The TTM CA patients had worse prehospital and admission GCS scores. All TTM CA patients had a prehospital GCS score of 3 to 8 compared to 85.1% of non-TTM CA patients (p < 0.01), and 98.8% of TTM versus 85.1% non-TTM CA patients had an admission GCS score of 3 to 8 (p < 0.01). In addition, the TTM CA patients also had longer time to ROSC and more nonshockable rhythm than the non-TTM patients (Table 2 ). However, 38.9% of initial rhythm and 44% of time to ROSC were unknown in this study (Supplemental Table 4 , Supplemental Digital Content, http://links.lww.com/TA/B161).
The TTM CA patients had worse unadjusted survival than the non-TTM CA patients (24.7% vs 39.4%, p < 0.05), and fewer TTM CA patients were discharged with good neurologic outcome (19.8% vs 37.2%, p < 0.05; Table 3 ). However, when subgroup analyses were performed between those with an admission GCS score of 3 to 8 from both groups, the differences between TTM and non-TTM CA survival (23.8% vs 30.0%, p = 0.37) and good neurologic outcome (18.8% vs 28.7%, p = 0.14) were not significant. The TTM CA patients had longer hospital length of stay (LOS), intensive care unit LOS, and time on mechanical ventilation. More TTM CA patients became organ donors than the non-TTM patients (52.5% vs 31.6%, p < 0.05). More TTM patients died from withdrawal of life-sustaining measures (72.1% vs 26.3%, p < 0.001), whereas more non-TTM CA patients died from brain death (52.6% vs 27.9%, p < 0.001; Table 2b ).
The 16 non-CA patients who received TTM also had higher severity of illness and worse outcome compared to the 477 non-TTM non-CA patients. The TTM non-CA patients had higher median ISS, Abbreviated Injury Scale Head score, worse prehospital GCS score, and worse admission GCS (Supplemental Table 2a , Supplemental Digital Content, http://links.lww.com/TA/B161). There were also more TTM non-CA patients with cerebral anoxia (50% vs 10.1%, p < 0.001).
The TTM non-CA patients had worse survival to hospital discharge (75% vs 97.3%, p < 0.001) and fewer discharged with good neurologic outcome (68.8% vs 95.2%, p < 0.001; Supplemental Table 2b , Supplemental Digital Content, http://links.lww. com/TA/B161).
Targeted temperature management was most frequently initiated with cold saline (44.3%) and external cooling device (59.8%). We developed CART models to identify variables that best predict the survival and neurologic outcome of all hanging patients (Figs. 2a, 2b) . The CA patients with an admission GCS score of greater than 6 had very high probability of survival (100%; AUROCC,0.926; Fig. 2a ). In addition, the CA patients with a prehospital GCS verbal score greater than 2 had very high probability of good neurologic outcome (100%; AUROCC,0.925; Fig. 2b ). The non-CA hanging patients with lowest SBP greater than 86 mm Hg within the first 6 hours had very high probability of survival (97.4%; AUROCC,0.926). For the non-CA patients who had SBP of 86 or less within the first 6 hours, those who were 29 years or younger had very high probability of survival Fig. 2a ). The non-CA patients with ISS of 19 or less had very high probability of good neurologic outcome (97.6%; AUROCC,0.925; Fig. 2b ). Because TTM was not randomly assigned in this study, we also developed separate CART models using TTM as the first split to predict the outcome of TTM hanging patients. Figure 3a shows that TTM patients with time to ROSC of more than 10 minutes and an admission GCS score of 4 or less had low probability of survival (4.3%; AUROCC,0.95). For the neurologic outcome of TTM hanging patients, those with time to ROSC of more than 7 minutes as well as an admission GCS score of 4 or less and cerebral anoxia had very low probability of good neurologic outcome (0%; AUROCC,0.937; Fig. 3b ). We then developed separate CART models to predict the outcome of TTM CA patients. The TTM CA patients who had admission lactate of greater than 7 mmol/L had very low probability of survival (3%; AUROCC,0.911; Fig. 4a ). While time to ROSC of more than 7 minutes and admission base excess greater than −9 mEq/L were predictive of poor neurologic outcome for the TTM CA patients (Fig. 4b) , these outcomes did not meet our predefined 3% or less for futility and the model was not as robust (AUROCC,0.864).
DISCUSSION
The results of this Eastern Association for the Surgery of Trauma multicenter retrospective study confirmed that CA hanging patients had higher severity of illness and worse outcome at hospital discharge than the non-CA patients. Our data also highlighted the significant societal burden imposed by suicidal hanging in the United States, with a median age of 32 years, 77% overall survival, and 28.6% CA survival. Our study further demonstrated the high incidence of psychiatric disorders, prior suicide attempts, and polysubstance abuse in hanging patients. These findings will help to identify vulnerable populations for suicide prevention and intervention.
Our data showed that hanging patients who received TTM had worse survival and neurologic outcome than non-TTM patients. These findings can be explained by several factors. The CA and non-CA patients who received TTM in this study had higher severity of illness, as demonstrated by their higher injury severity scores, prehospital and admission GCS scores, and incidence of cerebral anoxia. Targeted temperature management was likely applied to these sicker patients with the hope of improving their outcome. The association between the severity of illness and TTM CA patient outcome was supported by the lack outcome differences between the patients with an admission GCS score of 3 to 8. It was possible that the protective effect of TTM might have shifted the outcome of the more critically ill CA patients toward that of the non-TTM CA patients with similar severity of illness, resulting in the null effects observed in the subgroup analyses.
Another explanation for the worse outcome of TTM patients was the variability in TTM implementation and post-CA management were quite variable and prolonged in this study, with 61.7% and 28.9% unknown data, respectively (Supplemental Table 4 , Supplemental Digital Content, http://links.lww.com/TA/B161). Animal studies have shown that earlier initiation of TTM and time to target temperature of within 4 hours after ROSC can improve survival with good neurologic function. 29 However, these findings have not been consistently observed in human subjects. In recent studies, shorter time to target temperature was associated with worse outcome, 8, 30, 31 likely due to more significant brain injury and impaired thermoregulation in the shorter time to target temperature group. In addition, whether TTM patients were maintained in normothermia after rewarming was largely unknown in our study (66% unknown; Supplemental Table 4 , Supplemental Digital Content, http://links.lww.com/TA/B161). Pyrexia has been associated with worse outcome in post-CA survivors. 32, 33 As such, knowing whether the TTM patients were maintained in normothermia after rewarming would be critical for outcome analysis. Finally, we did not collect information regarding the hemodynamic goals, ventilator management, and sedative/paralytic use of these patients. It is possible that the different TTM implementation strategies and post-CA management nullified any protective effect of temperature management.
Another contributing factor to TTM outcome in this study was post-CA prognostication. Although we collected data regarding normothermia after rewarming, hospital LOS, CT brain results, and causes of death, it was unclear whether the participating centers followed consistent prognostication protocols throughout the study period. It is also likely the post-CA prognostication varied between the centers. Post-CA prognostication is best performed as a multimodal approach that includes clinical examination, electroencephalography, somatosensory evoked potential, biomarkers, and brain imaging. 34, 35 The timing of prognostication for the TTM patients is also critical. Recent retrospective studies have shown TTM to be associated with variable delay in awakening beyond 3 days after ROSC or rewarming. [36] [37] [38] [39] In addition to hypothermia, factors such as older age, renal insufficiency, and shock were also independent predictors of delayed awakening after CA. 37, 38 As the TTM CA patients in this study had median ICU LOS of 4 days (IQR, 3-7 days), it possible that some patients might have had premature prognostication and withdrawal of life-sustaining measures, which led to their seemingly worse survival due to self-fulfilling prophecy.
The benefit of TTM for nonshockable CA outcome is less clear, and it is possible that TTM may be harmful to survivors who sustained nonshockable CA. The randomized TTM trials to date have largely focused on shockable rhythms, and the expansion of TTM indication to nonshockable CA had been based on smaller retrospective studies. 8 Although there was significant unknown initial rhythm, we assume that most hanging-induced CA were nonshockable based on prior studies. 17, 40 In a propensitymatched analysis of 1,568 in-hospital CA survivors from the Get With the Guideline-Resuscitation Registry, Chan et al. found that TTM was associated with worse outcome. Although these differences held true for both the shockable and nonshockable rhythms, most of the patients in this study had nonshockable rhythms. 41 A multicenter, randomized, controlled study (HYPE-RION Trial) is currently ongoing to assess whether TTM is beneficial to comatose patients resuscitated after nonshockable CA. 42 Our data suggest that the complication rates associated with TTM in the hanging population were comparable to those of larger TTM trials. The most common complications in this study were electrolyte derangement (39.2%), seizure (27.8%), pneumonia (25.8%), and hemodynamic instability (23.7%). In the TTM trial with 473 patients randomized to 33°C, 93% of patients had at least one complication. There were 19% with hypokalemia, 44% with hypophosphatemia, 52% with pneumonia, 28% with myoclonic seizures, 9.1% with recurrent CA, and 5.2% with bradycardia that required pacing. 19 Kirkegaard et al. 18 found similar complication rates in 176 patients randomized to receive 24-hour TTM at 33°C ± 1°C. Taken together, our data suggest that TTM application to hanging patients had acceptable complication rates. We used CART to develop predictive models for survival and neurologic outcome with excellent accuracy. Classification and Regression Trees has multiple advantages over other analytic methods such as multivariate logistic regression. It is inherently nonparametric and thus makes no assumptions regarding the underlying distribution of the predictive values. 26, 27 Furthermore, it can handle missing data and highly skewed or multimodal variables by repeated sampling techniques. 43 Prior studies have used CART to develop useful models of CA outcome. 26, 27, [43] [44] [45] [46] We identified variables that can predict favorable survival and neurologic outcome of all hanging patients. Furthermore, we identified variables that were predictive of poor outcome in TTM patients. These poor outcome predictors may help guide families with care decisions, as significant resource utilization and emotional burden are often associated with post-CA care. Prior smaller retrospective studies have also identified SBP, 47 admission GCS score, 5, 16, 47 time to ROSC, 16 cerebral anoxia, and ISS 47 as predictors of hanging outcome.
This study has several limitations. It is a retrospective study with its inherent biases. Although this is the largest hanging outcome study from the United States, our TTM patient cohort size was still relatively small. Significant unknown data regarding TTM variables precluded us from definitive analyses of TTM implementation and post-CA care. Thus, it is difficult to ascertain the true effect of TTM on hanging-induced CA outcome without performing a multicenter randomized controlled study with more consistent management protocols and metrics database. Although we chose 3% or less as the cutoff for medical futility, more research is needed to identify the optimal decision algorithm preferred by patients, families, and health care providers. As the CART models may be unstable due to variable correlation and random fluctuation in data, 44 our models will need to be prospectively validated to confirm their accuracy. Finally, although we were not able to evaluate long-term outcome owing to unavailable data, previous studies have shown that CPC at hospital discharge correlated well with the long-term outcome of CA patients.
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CONCLUSION
Our data showed that hanging-induced CA patients had worse outcome than non-CA patients. Furthermore, our data suggest that hanging patients with higher severity of illness were more likely to receive TTM. Targeted temperature management patients had worse unadjusted survival and neurologic outcome at hospital discharge than the non-TTM patients. These findings may be explained by their higher severity of illness, variable TTM implementation, and differences in post-CA management and prognostication. Our CART models identified variables predictive of favorable and poor outcome. Future prospective studies with more comprehensive CA database are necessary to ascertain the effect of TTM on hanging outcome and to validate the CART models. 
EDITORIAL CRITIQUE
Doctors Claridge, Rodriguez, Yeh, President Crookes, and EAST members, I would like to thank the Association for the opportunity to discuss this paper. I must start first by disclosing that, in 2013, my wife underwent targeted temperature management for an out-of-hospital v-fib cardiac arrest, and, while one cannot prove causality in the complexity of a single case, I can tell you that her case is associated with an incredibly good outcome, and so, in general, I am a fan.
I won't re-present the data, but, briefly, the authors present a multi-institutional description of the characteristics and management of patients suffering hanging injuries. The collection of retrospective data spans seventeen institutions over twentyfive years, as the earliest patient included in this study was in 1992. Importantly, the first utilization of targeted temperature management strategies for these patients was noted in 2005.
Some major take-homes are, one, the EAST multicenter trial platform is an effective and valuable tool. Two, patients suffering hanging-induced cardiac arrest have worse outcomes than patients not suffering cardiac arrest, and I am comforted that my bias is confirmed.
Three, more severely-injured patients are more likely to receive targeted temperature management, also believable. Beyond this, I am not as sure about the current data analysis. The hypothesis proffered that a larger cohort would allow identification of targeted temperature associated outcome differences is sensible, but the appropriate analysis is then vital. I think the study would be strengthened greatly by multivariate analysis, understanding full well that missing data is a hindrance. I want to ask the authors some questions.
I understand that using the entire cohort for the overall predictors of outcomes, such as injury severity, presentation GCS, or cardiac arrest, but is the use of the entire cohort here really appropriate to compare the use of targeted temperature management and outcomes? Is it not more appropriate to compare from contemporary care of patients, that is only patients since 2005?
Can the neurologic management of patients in 1992 be considered equivalent to what we do now? Imaging alone has vastly changed. Further, as part of this study, have you collected information on the choice of how TTM is made, or the choice to use TTM is made? Are they comparable at these centers? How well did they achieve their targets? Since this really is an extrapolated indication, how well do the institutions perform with the classic indications of TTM for primary out-of-hospital cardiac arrest?
One might consider using these contemporary criteria for the use of TTM to construct the case control using the historical data, or, better, propensity analysis to identify historical patients who likely would have been chosen for TTM and did not receive it and then could serve as your control group in this larger cohort.
Even this might not be enough. Of the seventeen centers, three -I had the privilege of having the manuscript, and so you didn't miss something on the slides, but, of the seventeen centers, three did not perform a single TTM for hanging injuries. Presumably, they still do not, and a total of twelve centers performed six or less TTMs. Five of the centers account for seventy-four of the ninety-seven total TTM, or 76 percent. Did you consider comparing only patients from those centers that actually performed part of the TTM?
My biggest concern is that you're missing a benefit here. To consider a prospective study is nice, but I'm not sure that the data here would support that notion or the expense.
Lastly, the CART analysis that you saw just a very brief part is fascinating, but you have to tell us how this better would be helpful. Assuming that you can validate the model on more comprehensive data, can you truly use it?
What you didn't see is a patient who has return of spontaneous circulation greater than seven minutes and an admission GCS of three and an initial cerebral anoxia identified has a zero predicted chance of survival from this data. Are you brave enough to withhold TTM in that particular patient with those identifications? Thank you for the opportunity to discuss this paper.
